Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Samsung Biologics
Samsung Biologics
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
In wake of COVID-19 Medicom opens €88m nitrile glove facility in France
The PPE provider has opened the facility in response to Europe's dependence on nitrile glove imports, as revealed by the Covid-19 pandemic in 2020
IPS opens new branches in the UK and US
US-based IPS (Integrated Project Service) has expanded its reach by opening new branches in Alderley Park and Texas
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Impact of the new Annex 1 on sterile filling in pharma
EU GMP Annex 1 is a whole new era for the sterile filling industry. From barrier technology to “first air”, pharmaceutical manufacturers have a lot to decide. Johannes...
Medhini Group announces partnership with sustainable engineering consultancy
Medhini Group and TERAO Asia have joined forces to advance sustainable and green industrial projects in Malaysia
Upcoming event
Clinical Pharmacy Congress
10-11 May 2024 | Conference | London, UK
See all
Related Content
Pharmaceutical
Samsung Biologics selects company to automate microbiology QC testing
Samsung Biologics has selected Rapid Micro Biosystems’ Growth Direct platform to automate critical microbiology quality control testing
Sustainability
CDMO Samsung Biologics receives Terra Carta Seal for sustainable operations
The South Korean pharmaceutical CDMO has built an environmental management strategy that includes process optimisation, renewable energy transition, and minimising the use of single-use products
Pharmaceutical
Samsung Biologics appoints industry veteran as CEO
Samsung Biologics has announced John Rim as its President and CEO
Finance
Samsung Biologics plans $2bn 'Super Plant' for biomanufacturing
The company has also said that it is in negotiations with the authorities at Incheon Free Economic Zone to purchase additional land for its second bio complex
Pharmaceutical
Samsung BioLogics Plant 3 starts cGMP production
Facility in Incheon, South Korea, features 180,000L capacity, 20% more than its sister plant. The site passed validation in 10 months
Subscribe now